All
Research
Education
Araştırma
Eğitim
Business
Çözümler
TR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Oturum Aç
Department of Pulmonary Oncology
Yu Yuan has not added Biography.
If you are Yu Yuan and would like to personalize this page please email our Author Liaison for assistance.
High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma.
Journal of Cancer , 2020 | Pubmed ID: 32489463
Prediction of radiosensitivity and radiocurability using a novel supervised artificial neural network.
BMC cancer Dec, 2022 | Pubmed ID: 36451111
Chinese experts' consensus on the application of intensive care big data.
Frontiers in medicine , 2023 | Pubmed ID: 38264049
UBR1 promotes anaplastic thyroid carcinoma progression via stabilizing YAP through monoubiquitylation.
Scientific reports Aug, 2024 | Pubmed ID: 39174635
Roles and therapeutic opportunities of ω-3 long-chain polyunsaturated fatty acids in lung cancer.
iScience Jan, 2025 | Pubmed ID: 39834867
zhongnan hospital of Wuhan University
Yu Yuan*,1,
Ziyu Jiang*,2,
Yuxin Zeng1,
Jiawen Tang1,2,
Jiang Luo1,2,
Conghua Xie1,3,
Yan Gong2,3
1Department of Pulmonary Oncology, Zhongnan Hospital of Wuhan University,
2Tumor Precision Diagnosis and Treatment Technology and Translational Medicine, Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University,
3Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University
Gizlilik
Kullanım Şartları
İlkeler
Bize Ulaşın
KÜTÜPHANEYE TAVSİYE ET
JoVE HABER BÜLTENLERİ
JoVE Journal
Yöntem Koleksiyonları
JoVE Encyclopedia of Experiments
Arşiv
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Yazarlar
Kütüphaneciler
Erişim
JoVE Hakkında
JoVE Sitemap
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır